Obesity is more than a cosmetic concern. It’s a chronic disease that can be treated with drugs like semaglutide (Wegovy) and tirzepatide (Mounjaro). | Opinion ...

"Joint pain affects millions of Americans, leading to activity limitations and high medical costs. But groundbreaking research shows a new way to find relief. Could semaglutide be the answer to your ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Every January, millions of people start the new year vowing to lose weight. But in 2025, many of those hoping to shed the ...

In a world where weight loss and fitness take center stage, numerous products vie for attention, each promising remarkable ...

Ozempic has gotten most of the name recognition associated with weight-loss drugs, it's not the only drug in this category ...

This time last year, people were still bickering about whether Novo Nordisk's Wegovy and Eli Lilly & Co.'s Zepbound represented a shortcut to losing weight or a medical breakthrough. But with reams of ...

Professor Yoni Freedhoff claimed that changing eating and exercise habits will never be as effective as weight-loss drugs ...

Eli Lilly (LLY) emerges among the top performers in Big Pharma in 2024 with obesity drug success, while Novo Nordisk (NVO) ...

Both companies are longtime leaders in the pharmaceutical industry and have been making breakthroughs and delivering ...

Most  investors make a New Year's resolution to revamp their portfolio. But, in 2025, an unusual amount of uncertainty ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 500.39% and ...